{"id":1119,"date":"2026-02-06T09:42:45","date_gmt":"2026-02-06T09:42:45","guid":{"rendered":"https:\/\/isols2026.org\/?page_id=1119"},"modified":"2026-05-11T08:56:19","modified_gmt":"2026-05-11T08:56:19","slug":"preliminary-program","status":"publish","type":"page","link":"https:\/\/isols2026.org\/index.php\/preliminary-program\/","title":{"rendered":"Preliminary Program"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\n\t\n\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

(subject to change) <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tDownload the Preliminary Program in PDF<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Wednesday, September 23rd<\/sup>, 2026<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\u00a0<\/th>Stolz 1<\/strong> <\/span><\/th>Stolz 2<\/strong> <\/span><\/th><\/tr><\/thead>
08:00 \u2013 17:00<\/td>

ISOLS Young Surgeons Chondrosarcoma<\/strong><\/p>

Registration is required for attendance.<\/em>
Registration fee: 100.00 \u20ac<\/em><\/p>

To view the detailed pre-meeting program, click here<\/strong><\/a>.<\/p><\/td>

Musculoskeletal Tumour Surgery for Surgeons from Developing Countries<\/strong><\/p>

Attendance is included in the Meeting registration fee. <\/em><\/p>

To view the detailed pre-meeting program, click here<\/strong><\/a>.<\/p><\/td><\/tr>

17:00<\/td>ISOLS Young Surgeons Networking event <\/strong><\/span><\/td>\u00a0<\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Thursday, September 24th<\/sup>, 2026<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\u00a0<\/th>Lehar <\/span><\/strong><\/th>Stolz 1<\/strong> <\/span><\/th>Stolz 2<\/strong> <\/span><\/th>Shubert<\/strong> <\/span><\/th><\/tr><\/thead>
08:00 \u2013 08:45<\/td>\u00a0 Session 1.1: <\/span><\/strong> Infections I <\/strong><\/td>

Meet the professor (cases)<\/strong><\/p>

Speakers:<\/span>
Peter Steadman <\/strong>(Australia)
Mark Scarborough <\/strong>(United States)
Mikl\u00f3s Szendr\u014di <\/strong>(Hungary)<\/p><\/td>

\u00a0 Session 3.1:\u00a0<\/span><\/strong> Ultra Long-Term Outcomes of Megaprostheses<\/strong><\/td>\u00a0 Session 4.1:\u00a0<\/span><\/strong>Benign Bone Cysts<\/strong><\/td><\/tr>
08:45 \u2013 09:00<\/td>Morning break <\/strong><\/td><\/tr>
09:00 \u2013 10:30<\/td>

\u00a0 Session 1.2:\u00a0 <\/span><\/strong>Megaprostheses: Bigger, better, stronger?<\/strong><\/p>

Chairs: Panayiotis J. Papagelopoulos <\/strong>(Greece), Thomas Schubert <\/strong>(Belgium)\u00a0<\/span><\/p>

09:00 | William Aston <\/strong>(United Kingdom): Should HA collars be the standard in megaprosthetic replacement?<\/em><\/p>

09:10 | Koichi Ogura <\/strong>(Japan): Long-term complications and reoperations following distal femoral replacement<\/em><\/p>

09:20 | Lizz van der Heijden <\/strong>(The Netherlands): Paediatric patients: cemented vs. non-cemented megaprostheses?<\/em><\/p>

09:30 | Michael Parry <\/strong>(United Kingdom): Ultra long-term outcomes of patients with cemented megaprostheses<\/em><\/p>

09:40 | Eric Staals <\/strong>(Italy): Long term outcomes of patients with growing prostheses <\/em><\/p>

09:50 | Franics John Hornicek <\/strong>(United States): Which innovations do we need to lower the risk of mechanical failure?
<\/em><\/p>

DEBATE 1:<\/u><\/span><\/strong> Do we need a new ISOLS implant failure classification <\/strong>(Live Polling)<\/p>

10:00 | Emmy Nyqvist <\/strong>(Sweden): Great expectations, how can we know what the future will hold?<\/em><\/p>

10:07 | Eric Henderson:<\/strong> What’s in a name? That which we call a failure…<\/p>

10:14 | Discussion<\/p><\/td>

\u00a0 Session 2.1:\u00a0<\/span><\/strong>\u00a0Imaging Technicques<\/strong><\/p>

Chairs: Ilkyu Han<\/strong> (South Korea), Bernadette Liegl-Atzwanger<\/strong> (Austria)\u00a0<\/span><\/p>

09:00 | G. Douglas Letson<\/strong> (Unted States): Unmasking sarcomas. When do we biopsy?<\/em><\/p>

09:10 | Iris N\u00f6bauer <\/strong>(Austria): Gold-standard in imaging of soft tissue tumours in adults<\/em><\/p>

09:20 | Jasminka Igrec <\/strong>(Austria): Role of perfusion-weighted MRI in assessment of treatment response <\/em><\/p>

09:30 | Robert Phillips <\/strong>(New Zealand): Combining histology and radiology in treatment planning of sarcoma – Worth the effort?<\/em><\/p>

09:40 | Frank Traub <\/strong>(Germany): Intraoperative fluorescence-guided surgery for treatment of sarcomas<\/em><\/p>

09:50 | Oral Presentation<\/p>

09:55 | Oral Presentation<\/p>

10:00 | Oral Presentation<\/p>

10:05 | Oral Presentation<\/p>

10:10 | Oral Presentation<\/p>

10:15 | Oral Presentation<\/p>

10:20 | Discussion<\/p><\/td>

\u00a0 Session 3.2:\u00a0\u00a0<\/span><\/strong>Oral Presentations – Soft tissue sarcomas<\/strong><\/p>

Chairs: Lester Chan<\/strong> (Singapore), Daniel A. M\u00fcller<\/strong> (Switzerland)<\/p>

09:00 | Introductory lecture<\/u><\/strong><\/span> | Joanna Szkandera<\/strong> (Austria): Systemic therapies for advanced soft tissue sarcomas \u2013 New drugs, new hope?<\/em><\/p>

09:10 | Oral Presentation<\/p>

09:13 | Oral Presentation<\/p>

09:16 | Oral Presentation<\/p>

09:19 | Oral Presentation<\/p>

09:22 | Discussion<\/p>

09:30 | Oral Presentation<\/p>

09:33 | Oral Presentation<\/p>

09:36 | Oral Presentation<\/p>

09:39 | Oral Presentation<\/p>

09:42 | Discussion<\/p>

09:50 | Oral Presentation<\/p>

09:53 | Oral Presentation<\/p>

09:56 | Oral Presentation<\/p>

09:59 | Oral Presentation<\/p>

10:02 | Discussion<\/p>

10:10 | Oral Presentation<\/p>

10:13 | Oral Presentation<\/p>

10:16 | Oral Presentation<\/p>

10:19 | Oral Presentation<\/p>

10:22 | Discussion<\/p><\/td>

\u00a0 Session 4.2:\u00a0<\/span>\u00a0PROMS & Coping<\/strong><\/p><\/td><\/tr>

10:30 \u2013 11:00<\/td>Coffee break <\/strong><\/td><\/tr>
11:00 \u2013 12:30<\/td>

\u00a0 Session 1.3:\u00a0\u00a0<\/span><\/strong>Infections II<\/strong><\/p>

Chairs: Philipp Funovics<\/strong> (Austria), Minna Laitinen<\/strong> (Finland)<\/p>

11:00 | Michelle Ghert <\/strong>(Canada): Should PARITY change our practice? <\/em><\/p>

11:10 | Andrea Sambri <\/strong>(Italy): Role of two-stage revision for infected megaprostheses <\/em><\/p>

11:20 | Guy Morris <\/strong>(United Kingdom): The 10 most important BOOM findings on infections in oncology
<\/em><\/p>

DEBATE 2:<\/u><\/span><\/strong> Do we dare to DAIR? (Live Polling)<\/strong><\/p>

11:30 | Santiago Lozano Calderon <\/strong>(United States): Do we dare to DAIR? – Yes!<\/strong><\/span><\/p>

11:37 | Jendrik Hardes <\/strong>(Germany): Do we dare to DAIR? – No!<\/strong><\/span><\/p>

11:44 | Discussion<\/p>

12:00 | Oral Presentation<\/p>

12:05 | Oral Presentation<\/p>

12:10 | Oral Presentation<\/p>

12:15 | Oral Presentation<\/p>

12:20 | Discussion<\/p><\/td>

\u00a0 Session 2.2:\u00a0\u00a0<\/span><\/strong>Robotics – AI – Virtual surgery<\/strong><\/p>

Chairs: Ather Siddiqi<\/strong> (United Kingdom), Francisco Linares<\/strong> (Colombia)<\/p>

Educational Committee<\/u><\/span><\/p>

11:00 | Juan Pablo Zum\u00e1rraga<\/strong> (Ecuador): How Artificial Intelligence and Mixed Reality have changed my planning and patient Education<\/em><\/p>

11:15 | Ather Siddiqi<\/strong> (United Kingdom): MR an invaluable tool for surgical proctorship<\/em><\/p>

11:30 | Kwok Chuen Wong<\/strong> (China): Mixed Reality as spatial computing in orthopedic oncology (live demo)<\/em><\/p>

11:45 | Manish Agarwal<\/strong> (India): AI for segmentation and planning for 3D printed guides<\/em><\/p>

12:00 | Didactic lectures and live demo<\/p><\/td>

\u00a0 Session 3.3:\u00a0\u00a0<\/span><\/strong>From the Opertating Theare to Histopathology<\/strong><\/p>

Chairs: Scott Sommerville <\/strong>(Australia), Raymond Yau <\/strong>(China)<\/p>

09:00 | Introductory lecture<\/u><\/strong><\/span> | Bernadette Liegl-Atzwanger <\/strong>(Austria): The clinical implication of novel sarcoma variants <\/em><\/p>

11:10 | Oral Presentation<\/p>

11:13 | Oral Presentation<\/p>

11:16 | Oral Presentation<\/p>

11:19 | Oral Presentation<\/p>

11:22 | Discussion<\/p>

11:30 | Oral Presentation<\/p>

11:33 | Oral Presentation<\/p>

11:36 | Oral Presentation<\/p>

11:39 | Oral Presentation<\/p>

11:42 | Discussion<\/p>

11:50 | Oral Presentation<\/p>

11:53 | Oral Presentation<\/p>

11:56 | Oral Presentation<\/p>

11:59 | Oral Presentation<\/p>

12:02 | Discussion<\/p>

12:10 | Oral Presentation<\/p>

12:13 | Oral Presentation<\/p>

12:16 | Oral Presentation<\/p>

12:19 | Oral Presentation<\/p>

12:22 | Discussion<\/p><\/td>

\u00a0 Session 4.3:\u00a0<\/span>\u00a0<\/strong>Challenges in Sarcoma Management<\/strong><\/td><\/tr>
12:30 \u2013 13:30<\/td>Industry Lunch Symposium 1<\/strong><\/td>Lunch Break <\/strong><\/td><\/tr>
13:30 \u2013 14:30<\/td>

Opening session<\/strong><\/span><\/p>

Chairs: Pietro Ruggieri <\/strong>(Italy), Gerhard Hobusch<\/strong> (Austria)<\/p>

13:30 | TBA<\/strong><\/p>

13:55 | Andreas Leithner, Philipp Funovics, Gerhard Hobusch, Maria Anna Smolle<\/strong><\/p>

Welcome to Vienna\u00a0<\/u><\/strong><\/span><\/p>

14:00 | Philipp Funovics<\/strong> (Austria): Introduction<\/p>

14:05 | TBA <\/strong><\/p><\/td>

\u00a0<\/td>\u00a0<\/td>\u00a0<\/td><\/tr>
14:30 \u2013 15:30<\/td>

\u00a0 Session 1.4:\u00a0 <\/span><\/strong>Engineering<\/strong><\/p>

Chairs: Peter Steadman<\/strong> (Australia), Paul Unwin<\/strong> (United Kingdom)<\/p>

Crossfire – Poll<\/span><\/span><\/p>

14:30 | William Aston<\/strong> (United Kingdom): Prosthesis Standards <\/em><\/p>

14:40 | Kwok Chuen Wong<\/strong> (China): Mixed Reality \/ White Paper <\/em><\/p>

14:50 | Shintaro Iwata<\/strong> (Japan): AI \/ Imaging <\/em><\/p>

15:00 | Manish Agarwal<\/strong> (India): Jigs and Navigation<\/em><\/p>

15:10 | Oral Presentation best engineering abstract<\/p>

15:13 | Oral Presentation best engineering abstract<\/p>

15:16 | Oral Presentation best engineering abstract<\/p>

15:19 | Oral Presentation best engineering abstract<\/p>

17:22 | Discussion<\/p><\/td>

\u00a0 Session 2.3:\u00a0 <\/span><\/strong>PROMS<\/strong><\/p>

Chairs: Gerhard Hobusch<\/strong> (Austria), Shalin Patel<\/strong> (United States)<\/p>

Educational Committee<\/u><\/span><\/p>

14:30 | Krista Goulding<\/strong> (United States): PROM\u201dS: Where Are We Now<\/em><\/p>

14:40 | \u03a4\u0392\u0391<\/strong>: How PROM\u2019s Facilitate Measurement Of Post-Operative Recovery<\/em><\/p>

14:50 | Sherron Furtado<\/strong> (United Kingdom): Feasibility of Markerless Motion Capture for Functional Assessment<\/em><\/p>

15:00 | \u03a4\u0392\u0391<\/strong>: \u201cObtaining the data\u201d: How objective functional outcomes can improve our understanding and use of PROMs<\/em><\/p>

15:10 | Shalin Patel<\/strong> (United States): Translating and applying the data: How AI and Predictive Modeling can facilitate the real-time clinical<\/em> application of PROMs<\/p>

15:20 | Didactic lectures<\/p><\/td>

\u00a0 Session 3.4:\u00a0 <\/span><\/strong>Osteosarcoma<\/strong><\/td>\u00a0 Session 4.4:\u00a0<\/span>\u00a0<\/strong>Artificial Intelligence and Rrobotics<\/strong><\/td><\/tr>
15:30 \u2013 16:00<\/td>Coffee break <\/strong><\/td><\/tr>
16:00 \u2013 17:30<\/td>

\u00a0 Session 1.5:\u00a0\u00a0<\/span><\/strong>Protons, Ions, Carbons<\/strong><\/p>

Chairs: Xiaohui Niu<\/strong> (China), Susanne Scheipl<\/strong> (Austria)<\/p>

16:00 | Reiko Imai <\/strong>(Japan): The Role of Carbon Ion Radiotherapy in the Management of Bone and Soft Tissue Sarcomas<\/em><\/p>

16:10 | TBA<\/strong>: Updates from the SACRO study<\/em><\/p>

16:20 | Burkhard Lehner<\/strong> (Germany): Intraoperative radiotherapy for STS – Indications and limitations
<\/em><\/p>

DEBATE 3:<\/u><\/span> The chemo wars in STS: Friend, foe or futile? (Live Polling)<\/strong><\/p>

16:30 | Jay Wunder <\/strong>(Canada): The chemo wars in STS: Friend, foe or futile? – Futile!<\/em><\/p>

16:37 | Dimosthenis Andreou<\/strong> (Germany): The chemo wars in STS: Friend, foe or futile? – Friend!<\/em><\/p>

16:44 | Discussion<\/p>

17:00 | Oral Presentation 11<\/p>

17:05 | Oral Presentation 12<\/p>

17:10 | Oral Presentation 13<\/p>

17:15 | Oral Presentation 14<\/p>

17:20 | Discussion<\/p><\/td>

\u00a0 Session 2.4:\u00a0\u00a0<\/span><\/strong>Worst case ever – How we escaped (or not)<\/strong><\/p>

Chairs: Juan Pablo Zum\u00e1rraga <\/strong>(Ecuador), Valerae O. Lewis <\/strong>(United States)<\/p>

Educational Committee<\/span><\/span><\/p>

Faculty:
Manish Agarwal <\/strong>(India)
Reynaldo Jesus-Garcia <\/strong>(Brazil)
Valerae O. Lewis <\/strong>(United States)<\/p>

Case based presentation and discussion of complicated cases\/complications<\/p><\/td>

\u00a0 Session 3.5:\u00a0\u00a0<\/span><\/strong>Novel Therapeutics<\/strong><\/p>

Chair: C\u0103t\u0103lin C\u00eerstoiu<\/strong> (Romania)<\/p>

16:00 | Introductory lecture<\/u><\/strong><\/span> | Saminathan Suresh Nathan<\/strong> (Singapore): Emerging systemic therapies for bone and soft tissue sarcomas <\/em><\/p>

16:10 | Oral Presentation<\/p>

16:13 | Oral Presentation<\/p>

16:16 | Oral Presentation<\/p>

16:19 | Oral Presentation<\/p>

16:22 | Discussion<\/p>

16:30 | Oral Presentation<\/p>

16:33 | Oral Presentation<\/p>

16:36 | Oral Presentation<\/p>

16:39 | Oral Presentation<\/p>

16:42 | Discussion<\/p>

16:50 | Oral Presentation<\/p>

16:53 | Oral Presentation<\/p>

16:56 | Oral Presentation<\/p>

16:59 | Oral Presentation<\/p>

17:02 | Discussion<\/p>

17:10 | Oral Presentation<\/p>

17:13 | Oral Presentation<\/p>

17:16 | Oral Presentation<\/p>

17:19 | Oral Presentation<\/p>

17:22 | Discussion<\/p><\/td>

\u00a0 Session 4.5:\u00a0<\/span>\u00a0<\/strong>Paediatric Patients<\/strong><\/p><\/td><\/tr>

17:30 \u2013 18:00<\/td>

Presidential lecture<\/strong><\/p>

Chairs: Andreas Leithner <\/strong>(Austria), Maria Anna Smolle<\/strong> (Austria)<\/p>

17:30 | Claudia di Bella <\/strong>(Australia): Introduction<\/em><\/p>

17:35 | Peter Steadman <\/strong>(Australia): The Future of Orthopaedic Oncology: From Margins to Meaning: A vision for the next decade of collaboration and care <\/em><\/p><\/td>

\u00a0<\/td>\u00a0<\/td>\u00a0<\/td><\/tr>
18:00 \u2013 19:30<\/td>Welcome Reception<\/strong><\/span><\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Friday, September 25th<\/sup>, 2026<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\u00a0<\/th>Lehar <\/span><\/strong><\/th>Stolz 1<\/strong> <\/span><\/th>Stolz 2<\/strong><\/span><\/th>Schubert<\/strong><\/span><\/th><\/tr><\/thead>
08:00 \u2013 08:45<\/td>ISOLS General Assembly<\/strong><\/span><\/td>\u00a0<\/td>\u00a0<\/td>\u00a0<\/td><\/tr>
08:45 \u2013 09:00<\/td>Morning break <\/strong><\/td><\/tr>
09:00 \u2013 10:30<\/td>

\u00a0 Session 1.6:\u00a0 <\/span><\/strong>Innovations in paediatric sarcoma treatment<\/strong><\/p>

Chairs: Eduardo J. Ortiz-Cruz <\/strong>(Spain), Andreas Krieg<\/strong> (Switzerland)<\/p>

09:00 | Rob Pollock<\/strong> (United Kingdom): Megaprostheses in paediatric patients – Indications and limits <\/em><\/p>

09:10 | Eric Mascard <\/strong>(France): Vascularised vs. non-vascularised fibula in the paediatric patient <\/em><\/p>

09:20 | Joseph Benevenia <\/strong>(United States): Indications and outcomes of allograft reconstructions in the paediatric patient <\/em><\/p>

09:30 | Laura Campanacci <\/strong>(Italy): Hemiarthroplasty in very young children <\/em><\/p>

09:40 | Odion Binitie <\/strong>(United States): Results and complications of growing prostheses in paediatric patients <\/em><\/p>

09:50 | Michiel van de Sande <\/strong>(The Netherlands): The paediatric sarcoma patient – Just a tiny adult? <\/em><\/p>

10:00 | Nadine Williams <\/strong>(United States): Management of paediatric patients beyond surgery <\/em><\/p>

Difficult Cases – Poll<\/span><\/span><\/p>

10:10 | Christoph Hofer<\/strong> (Austria) & Anna Hohensteiner <\/strong>(Austria): 2 cases<\/p><\/td>

\u00a0\u00a0<\/span>Session 2.5:\u00a0 <\/span>Sarcoma Registry <\/strong><\/p>

Chairs: Joanna Szkandera <\/strong>(Austria), Masood Umer<\/strong> (Pakistan)<\/p>

09:00 | Benjamin Miller <\/strong>(United States): Introduction <\/em><\/p>

09:05 | Adam Levin<\/strong> (United States): What have we learned from sarcoma registries?
<\/em><\/p>

Best registry-focused abstracts from ISOLS abstract submission<\/p>

09:15 | Oral Presentation<\/p>

09:20 | Oral Presentation<\/p>

09:25 | Oral Presentation<\/p>

09:30 | Oral Presentation<\/p>

09:35 | Discussion<\/p>

09:45 | Update on International Sarcoma Registry Work Group<\/span><\/p>

Benjamin Miller\u00a0<\/strong>(United States):\u00a0Survey results<\/em><\/p>

Ashish Gulia <\/strong>(India): Future modules<\/em><\/p>

Marcos Galli <\/strong>(Argentina): Authorship and participation<\/em><\/p>

Benjamin Miller <\/strong>(United States), Joanna Szkandera <\/strong>(Austria): Interim project updates<\/em><\/p>

10:15 |\u00a0Session with audience engagement<\/span><\/p>

Luke Johnson <\/strong>(Australia),<\/span> Eric Staals <\/strong>(Italy)<\/span><\/p><\/td>

\u00a0 Session 3.6:\u00a0<\/span> <\/strong>Soft Tissue Sarcoma II<\/strong><\/p>

Chairs: Shintaro Iwata<\/strong> (Japan), Maya Niethard <\/strong>(Germany)<\/p>

09:00 | Introductory lecture<\/u><\/strong><\/span> | Steven Thorpe<\/strong> (United States): The value of intraoperative margin sampling in soft tissue sarcoma <\/em><\/p>

09:10 | Oral Presentation<\/p>

09:13 | Oral Presentation<\/p>

09:16 | Oral Presentation<\/p>

09:19 | Oral Presentation<\/p>

09:22 | Discussion<\/p>

09:30 | Oral Presentation<\/p>

09:33 | Oral Presentation<\/p>

09:36 | Oral Presentation<\/p>

09:39 | Oral Presentation<\/p>

09:42 | Discussion<\/p>

09:50 | Oral Presentation<\/p>

09:53 | Oral Presentation<\/p>

09:56 | Oral Presentation<\/p>

09:59 | Oral Presentation<\/p>

10:02 | Discussion<\/p>

10:10 | Oral Presentation<\/p>

10:13 | Oral Presentation<\/p>

10:16 | Oral Presentation<\/p>

10:19 | Oral Presentation<\/p>

10:22 | Discussion<\/p><\/td>

\u00a0 Session 4.6:\u00a0<\/span>Biological Reconstructions I<\/strong><\/p><\/td><\/tr>

10:30 \u2013 11:00<\/td>Coffee break <\/strong><\/td><\/tr>
11:00 \u2013 12:30<\/td>

\u00a0 Session 1.7:\u00a0 <\/span>Biological reconstruction – Growing back strong<\/strong><\/p>

Chairs: Eduardo Botello <\/strong>(Chile), Domenico A. Campanacci<\/strong> (Italy)<\/p>

11:00 | Ayman el Masry<\/strong> (Egypt): Single site osteotomy and frozen autograft for skeletal reconstruction in bone sarcoma management <\/em><\/p>

11:10 | Han-Soo Kim <\/strong>(Rep. of Korea): Sparing the tibial physis: Distal femur hemiarthroplasty and bone lengthening in children <\/em><\/p>

11:20 | Harzem \u00d6zger <\/strong>(Turkey): From Lexer and Juvara to Frozen Hotdog: the Istanbul Experience in Biological Reconstruction <\/em><\/p>

11:30 | Andreas Krieg <\/strong>(Switzerland): The Capanna technique in paediatric patients<\/em><\/p>

11:40 | Mikel San-Juli\u00e1n <\/strong>(Spain): Outcomes following reconstruction with the Canadell technique <\/em><\/p>

11:50 | Luis Alberto Aponte Tinao <\/strong>(Argentina): Long-term results of allograft reconstructions<\/em><\/p>

12:00 | Hindiskere Suraj <\/strong>(India): Surgical and oncological results of the telescope allograft technique in endoprosthetic reconstruction of the distal femur in children with a short proximal femur segment<\/em><\/p>

Difficult Cases – Poll<\/span><\/span><\/p>

12:10 Marisa Valentini<\/strong> (Austria)\u00a0& TBA<\/strong>: 2 cases<\/p><\/td>

\u00a0 Session 2.6:\u00a0 <\/span>Metal Ion Release in Tumour Endoprostheses – Clinical Relevance, Mechanisms, and Management<\/strong><\/p>

Chairs: John Healey <\/strong>(United States), Thomas Baad-Hansen<\/strong> (Denmark)<\/p>

11:00 | Keynote lecture<\/u><\/strong><\/span> | Minna Laitinen<\/strong> (Finland): Metal Ion Release in Orthopaedic Oncology: What Do We Know, and What Remains Unknown? <\/em><\/p>

11:10 | Sarah Freund<\/strong> (Denmark): Monitoring practices – How Do We Monitor Metal Ion Levels? Insights from the GAIIMES Survey <\/em><\/p>

11:17 | Matthew Houdek <\/strong>(United States): Mechanisms of metal ion release – Where Do the Ions Come From? Mechanical and Material Sources of Release <\/em><\/p>

11:24 | Hans Roland D\u00fcrr <\/strong>(Germany): Clinical impact of metal ions – From Ions to Illness: Adverse Events Linked to Metal Ion Release <\/em><\/p>

11:31 | Stefan Rakete<\/strong> (Germany):\u00a0Toxicological Perspectives – Systemic Metal Ion Exposure: Lessons from Toxicology and Occupational Medicine<\/em><\/p>

11:38 | Thomas Baad-Hansen <\/strong>(Denmark): Case-based clinical decision making – Managing Elevated Cobalt: What Would You Do? <\/em><\/p>

11:45 | Magdalena Maria Gilg <\/strong>(Austria): Future Monitoring, Consensus, and Research Priorities – Towards 2030: Standardizing Metal Ion Monitoring and Building Consensus <\/em><\/p>

11:52 | Panel discussion and audience Q&A<\/p><\/td>

\u00a0 Session 3.7:\u00a0 <\/span>Bone Sarcoma<\/strong><\/p>

Chairs: Davide Donati<\/strong> (Italy), Isidre Angel Gr\u00e0cia Alegria<\/strong> (Spain)<\/p>

11:00 | Introductory lecture<\/u><\/strong><\/span> | Alexander Lazarides<\/strong> (United States): Readmission rates in sarcoma patients <\/em><\/p>

11:10 | Oral Presentation<\/p>

11:13 | Oral Presentation<\/p>

11:16 | Oral Presentation<\/p>

11:19 | Oral Presentation<\/p>

11:22 | Discussion<\/p>

11:30 | Oral Presentation<\/p>

11:33 | Oral Presentation<\/p>

11:36 | Oral Presentation<\/p>

11:39 | Oral Presentation<\/p>

11:42 | Discussion<\/p>

11:50 | Oral Presentation<\/p>

11:53 | Oral Presentation<\/p>

11:56 | Oral Presentation<\/p>

11:59 | Oral Presentation<\/p>

12:02 | Discussion<\/p>

12:10 | Oral Presentation<\/p>

12:13 | Oral Presentation<\/p>

12:16 | Oral Presentation<\/p>

12:19 | Oral Presentation<\/p>

12:22 | Discussion<\/p><\/td>

\u00a0 Session 4.7:\u00a0 <\/span><\/strong>Spinal and Sacral Tumours<\/strong><\/p><\/td><\/tr>

12:30 \u2013 13:30<\/td>Industry Lunch Symposium 2<\/strong><\/td>\u00a0<\/td>\u00a0<\/td>\u00a0<\/td><\/tr>
13:30 \u2013 14:00<\/td>

ISOLS Lecture<\/strong><\/p>

Chair: Andreas Leithner <\/strong>(Austria), Andrea Angelini<\/strong> (Italy)<\/p>

13:30 | Andreas Leithner <\/strong>(Austria): Introduction <\/em><\/p>

13:35 | Ajay Puri <\/strong>(India): Reimplanting sterilised tumor bone: Irradiation or Cryotherapy – What works best? <\/em><\/p><\/td>

\u00a0<\/td>\u00a0<\/td>\u00a0<\/td><\/tr>
14:00 \u2013 15:30<\/td>

\u00a0 Session 1.8:\u00a0 <\/span>Pelvic reconstruction: The ring of fire<\/strong><\/p>

Chairs: Francis John Hornicek<\/strong> (United States), Per-Ulf Tunn<\/strong> (Germany)<\/p>

14:00 | Pietro Ruggieri <\/strong>(Italy): Pelvic sarcomas – The Padova experience <\/em><\/p>

14:10 | Vivek Ajit Singh <\/strong>(Malaysia): Reconstruction techniques following PII pelvic resections <\/em><\/p>

14:20 | Ashish Gulia <\/strong>(India): Biological reconstructions following internal hemipelvectomy <\/em><\/p>

14:30 | Vineet Kurisunkal <\/strong>(United Kingdom): The 10 most important BOOM findings<\/em><\/p>

14:40 | Wei Guo<\/strong> (China): Outcomes with custom-made 3D printed hemipelvic reconstructions<\/em><\/p>

14:50 | Arne Streitb\u00fcrger<\/strong> (Germany): Why we avoid megaprosthetic reconstruction following pelvic resection <\/em><\/p>

DEBATE 4<\/u><\/span><\/strong>\u00a0To close or not to close the ring? (Live Polling)<\/p>

15:00 | Lee Jeys<\/strong> (United Kingdom): To close or not to close the ring? – Yes!<\/strong><\/span><\/p>

15:07 | TBA<\/strong>: To close or not to close the ring? – No!<\/strong><\/span><\/p>

15:14 | Discussion<\/p><\/td>

\u00a0 Session 2.7:\u00a0 <\/span>Amputation vs. osseointegration vs. rotationplasty<\/strong><\/p>

Chairs: Gerhard Hobusch <\/strong>(Austria), Valerae O. Lewis<\/strong> (United States)<\/p>

Educational Committee<\/u><\/span><\/p>

14:00 | TBA<\/strong>: Novel techniques in amputation <\/em><\/p>

14:12 | James Flint<\/strong> (United States): Osseointegration: The \u03bfther Limb Salvage<\/em><\/p>

14:24 | Rickard Br\u00e5nemark <\/strong>(United States): OI – The vision and future aspects<\/em><\/p>

14:36 | Ajay Puri <\/strong>(India): Rotationplasty – When is it indicated?<\/em><\/p>

14:48 | Peter Bekkering <\/strong>(The Netherlands): The degree of physical activity and participation in sport after amputation and rotationplasty as a result of a malignant bone tumour in childhood <\/em><\/p>

15:00 | Discussion<\/p><\/td>

\u00a0 Session 3.8:\u00a0 <\/span>Socio-Economic Disparities in Sarcoma Care<\/strong><\/p>

Chairs: Thomas Hilton <\/strong>(South Africa), Oleg Vyrva <\/strong>(Ukraine)<\/p>

14:00 | Introductory lecture<\/u><\/strong><\/span> | Claudia Di Bella<\/strong> (Australia): Women in surgery<\/em><\/p>

14:10 | Oral Presentation<\/p>

14:13 | Oral Presentation<\/p>

14:16 | Oral Presentation<\/p>

14:19 | Oral Presentation<\/p>

14:22 | Discussion<\/p>

14:30 | Oral Presentation<\/p>

14:33 | Oral Presentation<\/p>

14:36 | Oral Presentation<\/p>

14:39 | Oral Presentation<\/p>

14:42 | Discussion<\/p>

14:50 | Oral Presentation<\/p>

14:53 | Oral Presentation<\/p>

14:56 | Oral Presentation<\/p>

14:59 | Oral Presentation<\/p>

15:02 | Discussion<\/p>

15:10 | Oral Presentation<\/p>

15:13 | Oral Presentation<\/p>

15:16 | Oral Presentation<\/p>

15:19 | Oral Presentation<\/p>

15:22 | Discussion<\/p><\/td>

\u00a0 Session 4.8:\u00a0 <\/span><\/strong>Biological Reconstructions II<\/strong><\/p><\/td><\/tr>

15:30 \u2013 16:00<\/td>Coffee break <\/strong><\/td><\/tr>
16:00 \u2013 17:00<\/td>

\u00a0 Session 1.9:\u00a0 <\/span>Margins – A marginal difference may be vital<\/strong><\/p>

Chairs: Peter Rose <\/strong>(United States), Han-Soo Kim<\/strong> (Rep. of Korea)<\/p>

16:00 | Paul Jutte<\/strong> (The Netherlands): Which margin is considered \u201cwide\u201d for bone sarcomas? <\/em><\/p>

16:10 | Tomohiro Fujiwara <\/strong>(Japan): Which margin is considered \u201cwide\u201d for soft-tissue sarcomas? – Practical integration of margin quantity and quality <\/em><\/p>

16:20 | Walid Ebeid <\/strong>(Egypt): Challenges to achieve \u201cwide\u201d margins in periarticular bone tumours of the knee <\/em><\/p>

Difficult Cases – Poll<\/span><\/span><\/p>

16:30 | Magdalena Maria Gilg <\/strong>(Austria) & Julia von der Linden <\/strong>(Austria): 2 cases<\/p><\/td>

\u00a0 Session 2.8:\u00a0 <\/span>Challenges, limitations and potential solutions for Sarcoma Care in Developing Countries<\/strong><\/p>

Chairs: Francisco Linares<\/strong> (Colombia), Santiago Lozano Calderon<\/strong> (United States)<\/p>

16:00 | TBA<\/strong>: Challenges and Limitations in Sarcoma Care in Developing Countries<\/em><\/p>

16:12 | David Wood<\/strong> (Australia): Resource Stratified Guideline for Optimization of Sarcoma Care in Developing Countries: The Experience in the Asia-Pacific Region<\/em><\/p>

16:24 | Case Experiences: Introductions with Juan Pablo Zum\u00e1rraga<\/strong> (Ecuador)<\/p>

16:27 | TBA<\/strong>: South America<\/em><\/p>

16:32 | Ermias Gizaw Hailemeskel<\/strong> (Ethiopia): Africa<\/em><\/p>

16:37 | TBA<\/strong>: Asia<\/em><\/p>

16:42 | Ather Siddiqi<\/strong> (Pakistan): Middle East<\/em><\/p>

16:47 | Discussion and questions<\/p><\/td>

\u00a0 Session 3.9:\u00a0 <\/span>GCT<\/strong><\/td>\u00a0 Session 4.9:\u00a0 <\/span>Rotationplastry<\/strong><\/td><\/tr>
17:00 \u2013 18:00<\/td>

Pioneers of ISOLS (Round Table Discussion)<\/strong><\/p>

Chair: Philipp Funovics <\/strong>(Austria)<\/p>

Speakers:<\/span>
Rainer Kotz <\/strong>(Austria)
Winfried Winkelmann <\/strong>(Germany)
Franklin Sim <\/strong>(United States)
Hiroyuki Tsuchiya <\/strong>(Japan)<\/p><\/td>

\u00a0 Session 2.9: <\/span>Minimally invasive techniques for metastatic disease<\/strong><\/p>

Chairs: Kista Goulding<\/strong> (United States), Karim Masrouha<\/strong> (United States)<\/p>

Educational Committee<\/u><\/span><\/p>

17:00 | Francis Y. Lee<\/strong> (United States): Biomechanical, Onco-Biology, and Clinical Outcomes of Minimally Invasive Management of Skeletal Metastases<\/em><\/p>

17:10 | Santiago Lozano Calderon<\/strong> (United States): Photodynamic nails in the management of metastatic bone disease: Minimally invasive techniques<\/em><\/p>

17:20 | Tomas Zamora<\/strong> (Chile)<\/p>

17:30 | Brooke M. Crawford<\/strong> (United States): Difficulties and considerations when performing percutaneous procedures for skeletal metastatic disease<\/em><\/p>

17:40 | Case based discussion\/lecture and Informational lectures<\/p><\/td>

\u00a0 Session 3.10:\u00a0 <\/span>Basic Science I<\/strong><\/p>

Chairs: Claudia Di Bella <\/strong>(Australia), Frank Traub <\/strong>(Germany)<\/p>

17:00 | Introductory lecture<\/u><\/strong><\/span> | Peter Rose <\/strong>(United States): From bench to bedside <\/em><\/p>

17:10 | Oral Presentation<\/p>

17:13 | Oral Presentation<\/p>

17:16 | Oral Presentation<\/p>

17:19 | Oral Presentation<\/p>

17:22 | Oral Presentation<\/p>

17:25 | Discussion<\/p>

17:35 | Oral Presentation<\/p>

17:38 | Oral Presentation<\/p>

17:41 | Oral Presentation<\/p>

17:44 | Oral Presentation<\/p>

17:47 | Oral Presentation<\/p>

17:50 | Discussion<\/p><\/td>

\u00a0 Session 4.10:\u00a0 <\/span>Biological Reconstructions III<\/strong><\/p><\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Saturday, September 26th<\/sup>, 2026<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\n\n\n\n\n\n
<\/th>\nLehar <\/span><\/strong><\/th>\nStolz 1<\/strong> <\/span><\/th>\nStolz 2<\/strong><\/span><\/th>\nSchubert<\/strong> <\/span><\/th>\n<\/tr>\n<\/thead>\n
08:00 \u2013 08:45<\/td>\n\u00a0 Session 1.10:\u00a0 <\/span>Upper Extremity I<\/strong><\/td>\nMeet the professor (cases)<\/strong>\n

Speakers:<\/span>\nRobert Lawrence Randall <\/strong>(United States)\nMichelle Ghert <\/strong>(Canada)\nMarco Manfrini <\/strong>(Italy)<\/p>\n<\/td>\n

\u00a0 Session 3.11:\u00a0 <\/span>Advanced Metastatic Setting I<\/strong><\/td>\n\u00a0 Session 4.11:\u00a0 <\/span><\/strong>Of Bone and Bold Ideas<\/strong><\/td>\n<\/tr>\n
08:45 \u2013 09:00<\/td>\nMorning break <\/strong><\/td>\n<\/tr>\n
09:00 \u2013 10:00<\/td>\n\u00a0 Session 1.11:\u00a0 <\/span>The Famous ISOLS Quiz<\/strong>\n\nChairs: Philipp Funovics <\/strong>(Austria) – Lee Jeys <\/strong>(United Kingdom)<\/td>\n\u00a0 Session 2.10:\u00a0 <\/span>Upper Extremity II<\/strong>\n\nChairs: Ana Cecilia Belzarena<\/strong> (Unites States), Elisa Pala<\/strong> (Italy)\n

09:00 | Introductory lecture<\/u><\/strong><\/span> | Panayiotis J. Papagelopoulos <\/strong>(Greece): Custom-made implants for periscapular sarcomas <\/em><\/p>\n

09:10 | Oral Presentation<\/p>\n

09:13 | Oral Presentation<\/p>\n

09:16 | Oral Presentation<\/p>\n

09:19 | Oral Presentation<\/p>\n

09:22 | Oral Presentation<\/p>\n

09:25 | Discussion<\/p>\n

09:35 | Oral Presentation<\/p>\n

09:38 | Oral Presentation<\/p>\n

09:41 | Oral Presentation<\/p>\n

09:44 | Oral Presentation<\/p>\n

09:47 | Oral Presentation<\/p>\n

09:50 | Discussion<\/p>\n<\/td>\n

\u00a0 Session 3.12:\u00a0 <\/span>Advanced Metastatic Setting II<\/strong>\n\nChair: Justin E. Bird<\/strong> (United States), Fabrice Fiorenza<\/strong> (France)\n

09:00 | Introductory lecture<\/u><\/strong><\/span> | Andrea Angelini <\/strong>(Italy): Therapeutic approaches in patients with spine metastases <\/em><\/p>\n

09:10 | Oral Presentation<\/p>\n

09:13 | Oral Presentation<\/p>\n

09:16 | Oral Presentation<\/p>\n

09:19 | Oral Presentation<\/p>\n

09:22 | Oral Presentation<\/p>\n

09:25 | Discussion<\/p>\n

09:35 | Oral Presentation<\/p>\n

09:38 | Oral Presentation<\/p>\n

09:41 | Oral Presentation<\/p>\n

09:44 | Oral Presentation<\/p>\n

09:47 | Oral Presentation<\/p>\n

09:50 | Discussion<\/p>\n<\/td>\n

\n

\u00a0 Session 4.12:\u00a0 <\/span><\/strong>Osseointegration and Rotationplasty<\/strong><\/p>\n<\/td>\n<\/tr>\n

10:00 \u2013 11:00<\/td>\n\u00a0 Session 1.12:\u00a0 <\/span>\u00a0Soft tissue sarcomas<\/strong>\n\nChairs: Joanna Szkandera<\/strong> (Austria), Xiadong Tang<\/strong> (China)\n

10:00 | Jean Philippe Dulude <\/strong>(Australia): Intraoperative use of high-speed Raman spectroscopy during soft tissue sarcoma resection<\/em><\/p>\n

10:10 | Kenneth Rankin <\/strong>(United Kingdom): Indeterminate pulmonary nodules upon diagnosis of soft tissue sarcoma -\u202fImpact on treatment decision and prognosis <\/em><\/p>\n

10:20 | Maria Anna Smolle<\/strong> (Austria): Frequency of venous thromboembolisms in patients undergoing surgery for STS <\/em><\/p>\n

10:30 | TBA<\/strong>: Antiangiogenic agents and PD-1 inhibitors for advanced soft tissue sarcoma <\/em><\/p>\n

Difficult Cases – Poll<\/span><\/span><\/p>\n

10:40 | Sophie Joch<\/strong> (Austria) & Cristian Pauritsch<\/strong> (Austria): 2 cases<\/p>\n<\/td>\n

\u00a0 Session 2.11:\u00a0\u00a0<\/span>Liquid Biopsy \u2013 Tumour Biology<\/strong>\n\nChairs: Giorge Loria<\/strong> (Georgia), Nikolaos Stavropoulos<\/strong> (Greece)\n

10:00 | Introductory lecture<\/u><\/strong><\/span> | Toshifumi Ozaki <\/strong>(Japan): Advancing Sarcoma Care: Integrating Liquid Biopsy and Genomic Profiling for Precision Medicine <\/em><\/p>\n

10:10 | Oral Presentation<\/p>\n

10:13 | Oral Presentation<\/p>\n

10:16 | Oral Presentation<\/p>\n

10:19 | Oral Presentation<\/p>\n

10:22 | Oral Presentation<\/p>\n

10:25 | Discussion<\/p>\n

10:35 | Oral Presentation<\/p>\n

10:38 | Oral Presentation<\/p>\n

10:41 | Oral Presentation<\/p>\n

10:44 | Oral Presentation<\/p>\n

10:47 | Oral Presentation<\/p>\n

10:50 | Discussion<\/p>\n<\/td>\n

\u00a0 Session 3.13:\u00a0\u00a0<\/span>TGCTs<\/strong>\n\nChairs: <\/span>Michele Boffano<\/strong> (Italy),<\/span> Mehmet Ali Deveci <\/strong>(Turkey)<\/span>\n

10:00 | Introductory lecture<\/u><\/strong><\/span> |\u00a0Nicholas Bernthal <\/strong>(United States): Targeted therapy for tenosynovial giant cell tumour – Worth the costs? <\/em><\/p>\n

10:10 | Oral Presentation<\/p>\n

10:13 | Oral Presentation<\/p>\n

10:16 | Oral Presentation<\/p>\n

10:19 | Oral Presentation<\/p>\n

10:22 | Oral Presentation<\/p>\n

10:25 | Discussion<\/p>\n

10:35 | Oral Presentation<\/p>\n

10:38 | Oral Presentation<\/p>\n

10:41 | Oral Presentation<\/p>\n

10:44 | Oral Presentation<\/p>\n

10:47 | Oral Presentation<\/p>\n

10:50 | Oral Presentation<\/p>\n<\/td>\n

\n

\u00a0 Session 4.13:\u00a0 <\/span>Pelvic Resections and Reconstructions<\/strong><\/p>\n<\/td>\n<\/tr>\n

11:00 \u2013 12:00<\/td>\nCoffee break & Poster Walk <\/strong><\/td>\n<\/tr>\n
12:00 \u2013 13:30<\/td>\n\u00a0 Session 1.13:\u00a0 <\/span>Benign aggressive tumours<\/strong>\n\nChairs: Francisco Linares <\/strong>(Colombia), Nicole Montgomery <\/strong>(United States)\n

Educational Committee<\/span><\/p>\n

12:00 | Ashish Gulia <\/strong>(India): Minimally invasive manage of benign bone tumors<\/p>\n

12:15 | TBA<\/strong>: History of GCT<\/p>\n

12:30 | Hairong Xu <\/strong>(China): Evolving concepts in the treatment of Aneurysmal Bone Cyst<\/p>\n

12:45 | TBA<\/strong>: Medical Advances in Bening Bone Disease<\/p>\n

13:00 | Didactic lectures<\/p>\n

<\/p>\n<\/td>\n

\u00a0 Session 2.12:\u00a0 <\/span>The very young and the very old<\/strong>\n\nChairs: Valerae O. Lewis <\/strong>(United States), Juan Pablo Zum\u00e1rraga<\/strong> (Ecuador)\n

Educational Committee<\/span><\/p>\n

Walid Ebeid <\/strong>(Egypt)<\/p>\n

Wakenda Tyler <\/strong>(United States)<\/p>\n

Wan Faisham Nu\u2018man Wan Ismail <\/strong>(Malaysia)<\/p>\n

Case-based discussion<\/p>\n<\/td>\n

\u00a0 Session 3.14:\u00a0 <\/span>Megaprostheses & Metal Ions<\/strong>\n\nChairs: Min Wook Joo<\/strong> (Rep. of Korea), Hazem Wafa<\/strong> (Belgium)\n

12:00 | Introductory lecture<\/u><\/strong><\/span> | Fabrice Fiorenza <\/strong>(France): Custom-made solutions \u2013 Are they worth the cost?<\/em><\/p>\n

12:10 | Oral Presentation<\/p>\n

12:13 | Oral Presentation<\/p>\n

12:16 | Oral Presentation<\/p>\n

12:19 | Oral Presentation<\/p>\n

12:22 | Discussion<\/p>\n

12:30 | Oral Presentation<\/p>\n

12:33 | Oral Presentation<\/p>\n

12:36 | Oral Presentation<\/p>\n

12:39 | Oral Presentation<\/p>\n

12:42 | Discussion<\/p>\n

12:50 | Oral Presentation<\/p>\n

12:53 | Oral Presentation<\/p>\n

12:56 | Oral Presentation<\/p>\n

12:59 | Oral Presentation<\/p>\n

13:02 | Discussion<\/p>\n

13:10 | Oral Presentation<\/p>\n

13:13 | Oral Presentation<\/p>\n

13:16 | Oral Presentation<\/p>\n

13:19 | Oral Presentation<\/p>\n

13:22 | Discussion<\/p>\n<\/td>\n

\n

\u00a0 Session 4.14:\u00a0 <\/span>Basic Sciences II<\/strong><\/p>\n<\/td>\n<\/tr>\n

13:30 \u2013 14:00<\/td>\nClosing<\/strong><\/span><\/td>\n<\/tr>\n
15:00\u2013 18:00<\/td>\nMedical History of Vienna <\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

(subject to change) Download the Preliminary Program in PDF Wednesday, September 23rd, 2026 \u00a0 Stolz 1 Stolz 2 08:00 \u2013 17:00 ISOLS Young Surgeons Chondrosarcoma Registration is required for attendance.Registration fee: 100.00 \u20ac To view the detailed pre-meeting program, click here. Musculoskeletal Tumour Surgery for Surgeons from Developing Countries Attendance is included in the Meeting […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-1119","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/pages\/1119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/comments?post=1119"}],"version-history":[{"count":164,"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/pages\/1119\/revisions"}],"predecessor-version":[{"id":1474,"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/pages\/1119\/revisions\/1474"}],"wp:attachment":[{"href":"https:\/\/isols2026.org\/index.php\/wp-json\/wp\/v2\/media?parent=1119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}